Cargando…

Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature

A 31-year-old woman presented with a nasal voice, dysarthria, and upper limb weakness during her first pregnancy. Soon after delivery of her first baby, her symptoms disappeared. At the age of 34 years, during her second pregnancy, her nasal voice re-appeared. After delivery of the second baby, her...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Ken-ichi, Tsugawa, Jun, Fukae, Jiro, Fukuhara, Kosuke, Kawano, Hiroyasu, Fujioka, Shinsuke, Tsuboi, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154260/
https://www.ncbi.nlm.nih.gov/pubmed/32308606
http://dx.doi.org/10.1159/000506189
_version_ 1783521793841037312
author Inoue, Ken-ichi
Tsugawa, Jun
Fukae, Jiro
Fukuhara, Kosuke
Kawano, Hiroyasu
Fujioka, Shinsuke
Tsuboi, Yoshio
author_facet Inoue, Ken-ichi
Tsugawa, Jun
Fukae, Jiro
Fukuhara, Kosuke
Kawano, Hiroyasu
Fujioka, Shinsuke
Tsuboi, Yoshio
author_sort Inoue, Ken-ichi
collection PubMed
description A 31-year-old woman presented with a nasal voice, dysarthria, and upper limb weakness during her first pregnancy. Soon after delivery of her first baby, her symptoms disappeared. At the age of 34 years, during her second pregnancy, her nasal voice re-appeared. After delivery of the second baby, her nasal voice worsened, and bilateral eyelid ptosis and easy fatigability were also evident. She was referred to our hospital. Because of her myasthenic symptoms and anti-muscle-specific tyrosine kinase (MuSK) antibody (Ab)-positive status, she was diagnosed as having myasthenia gravis (MG). Her symptoms were worse than those in her first pregnancy. She was treated with oral steroid and double filtration plasmapheresis. After initiation of treatment, her myasthenic symptoms improved completely. In addition, her baby developed transient neonatal MG (TNMG) on the fourth day after birth and then gradually recovered over 30 days. It should be noted that symptoms of patients with anti-MuSK Ab-positive MG (MuSK-MG) can deteriorate during pregnancy, and the babies delivered of patients with MuSK-MG have a high probability of developing TNMG.
format Online
Article
Text
id pubmed-7154260
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-71542602020-04-19 Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature Inoue, Ken-ichi Tsugawa, Jun Fukae, Jiro Fukuhara, Kosuke Kawano, Hiroyasu Fujioka, Shinsuke Tsuboi, Yoshio Case Rep Neurol Single Case − General Neurology A 31-year-old woman presented with a nasal voice, dysarthria, and upper limb weakness during her first pregnancy. Soon after delivery of her first baby, her symptoms disappeared. At the age of 34 years, during her second pregnancy, her nasal voice re-appeared. After delivery of the second baby, her nasal voice worsened, and bilateral eyelid ptosis and easy fatigability were also evident. She was referred to our hospital. Because of her myasthenic symptoms and anti-muscle-specific tyrosine kinase (MuSK) antibody (Ab)-positive status, she was diagnosed as having myasthenia gravis (MG). Her symptoms were worse than those in her first pregnancy. She was treated with oral steroid and double filtration plasmapheresis. After initiation of treatment, her myasthenic symptoms improved completely. In addition, her baby developed transient neonatal MG (TNMG) on the fourth day after birth and then gradually recovered over 30 days. It should be noted that symptoms of patients with anti-MuSK Ab-positive MG (MuSK-MG) can deteriorate during pregnancy, and the babies delivered of patients with MuSK-MG have a high probability of developing TNMG. S. Karger AG 2020-03-17 /pmc/articles/PMC7154260/ /pubmed/32308606 http://dx.doi.org/10.1159/000506189 Text en Copyright © 2020 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case − General Neurology
Inoue, Ken-ichi
Tsugawa, Jun
Fukae, Jiro
Fukuhara, Kosuke
Kawano, Hiroyasu
Fujioka, Shinsuke
Tsuboi, Yoshio
Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature
title Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature
title_full Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature
title_fullStr Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature
title_full_unstemmed Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature
title_short Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature
title_sort myasthenia gravis with anti-muscle-specific tyrosine kinase antibody during pregnancy and risk of neonatal myasthenia gravis: a case report and review of the literature
topic Single Case − General Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154260/
https://www.ncbi.nlm.nih.gov/pubmed/32308606
http://dx.doi.org/10.1159/000506189
work_keys_str_mv AT inouekenichi myastheniagraviswithantimusclespecifictyrosinekinaseantibodyduringpregnancyandriskofneonatalmyastheniagravisacasereportandreviewoftheliterature
AT tsugawajun myastheniagraviswithantimusclespecifictyrosinekinaseantibodyduringpregnancyandriskofneonatalmyastheniagravisacasereportandreviewoftheliterature
AT fukaejiro myastheniagraviswithantimusclespecifictyrosinekinaseantibodyduringpregnancyandriskofneonatalmyastheniagravisacasereportandreviewoftheliterature
AT fukuharakosuke myastheniagraviswithantimusclespecifictyrosinekinaseantibodyduringpregnancyandriskofneonatalmyastheniagravisacasereportandreviewoftheliterature
AT kawanohiroyasu myastheniagraviswithantimusclespecifictyrosinekinaseantibodyduringpregnancyandriskofneonatalmyastheniagravisacasereportandreviewoftheliterature
AT fujiokashinsuke myastheniagraviswithantimusclespecifictyrosinekinaseantibodyduringpregnancyandriskofneonatalmyastheniagravisacasereportandreviewoftheliterature
AT tsuboiyoshio myastheniagraviswithantimusclespecifictyrosinekinaseantibodyduringpregnancyandriskofneonatalmyastheniagravisacasereportandreviewoftheliterature